... at this age. The findings of our study, in combination with results of the evolving literature on HPV vaccine acceptability, provide information that can be used to improve moms’ acceptance of HPV ...
... Cervarix.
Jit and colleagues predict that the HPV vaccination programme in the UK aimed at 12 year- ... 13 less per dose than the quadrivalent vaccine translates to financial savings of between £11.5 ...
Severe side effects of the HPV vaccine Gardasil appear to be rare, according to a study that may help calm fears of some parents as schools prepare for another round of vaccinations against one of the ...
... http://www.cmaj.ca/press/179_6_503.pdf states that this study indicates the HPV ... community "to restart public discussions about the safety of the HPV vaccine, the precautions taken to mitigate risks ...
... Cervarix for the UK human papillomavirus (HPV) vaccination programme, every doctor I have spoken ... mention on the NHS Choices website or on the NHS vaccination site.
He believes that for any licensed ...
... Kimmel Cancer Center investigator. Leading HPV expert Maura Gillison, M.D., ... need to have a more comprehensive discussion of the potential impact the HPV vaccine could have on cancer rates among men ...
... HPV vaccine as a condition for school attendance. Gail Javitt, J.D., M.P.H., ... raise several concerns about state mandates for HPV vaccination.
To begin with, they assert that Gardasil is relatively ...
... doses, finds the first evaluation of the quadrivalent HPV vaccine published on bmj.com today. ... Reports of some adverse events followed the school vaccination programme.
Dr Sharon Choo and colleagues ...
... D., professor of medicine in the Infectious Diseases Division of the University of Pennsylvania.
The HPV vaccine, approved for use in the United States as Gardasil and manufactured by Merck and Co., ...
Some provinces with the tightest restrictions on HPV vaccination also have the highest rates of cervical cancer, according to a report released Tuesday by the Cancer Advocacy Coalition of Canada. The ...
... along with other vaccines.
"Our results show that Guillain-Barré is not occurring more often after HPV vaccination than it does in the general population," said study author Nizar Souayah, MD, of ...
The HPV vaccine does not increase the risk of developing Guillain-Barre syndrome, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting ...
... young women in California say they would like to have the vaccine, according to a new policy brief released today ... Health Policy Research, collected data on HPV vaccine acceptance from July 2007 through ...
The HPV vaccine does not increase the risk of developing Guillain-Barre syndrome, according to a new study. Guillain-Barre is a disorder that causes muscle weakness and tingling that can progress to ...
... their likelihood of accepting vaccination for themselves or their children. When asked about their sources of knowledge about the HPV vaccine, Latino women reported their health care provider was the ...
